| 2026-05-08 |
详情>>
内部人交易：
GRASBY PAUL DARREN股份减少24376.00股
|
| 2026-05-06 |
详情>>
股本变动：
变动后总股本163060.06万股
|
| 2026-05-06 |
详情>>
业绩披露：
2026年一季报每股收益0.85美元,归母净利润13.83亿美元,同比去年增长95.06%
|
| 2026-05-05 |
财报披露：
美东时间 2026-05-05 盘后发布财报
|
| 2026-03-27 |
股东大会：
将于2026-05-13召开股东大会
会议内容 ▼▲
- 1.Elect the eight director nominees named in this proxy statement;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the current fiscal year;
3.Approve on a non-binding, advisory basis the compensation of our named executive officers (“Say-on-Pay”), as disclosed in this proxy statement pursuant to the compensation disclosure rules of the U.S. Securities and Exchange Commission (the “SEC”);
4.Approve the amendment and restatement of the Advanced Micro Devices, Inc. 2023 Equity Incentive Plan (as amended and restated, the “2023 Plan”) to: (i) increase the number of authorized shares that can be issued to employees, consultants and directors under the 2023 Plan by 65 million shares and (ii) update the plan for certain administrative changes;
5.Vote on the stockholder proposal described in this proxy statement, if properly presented at our Annual Meeting;
6.Transact any other business that properly comes before our Annual Meeting or any adjournment or postponement thereof.
|
| 2026-02-04 |
详情>>
业绩披露：
2025年年报每股收益2.67美元,归母净利润43.35亿美元,同比去年增长164.17%
|
| 2026-02-04 |
详情>>
业绩披露：
2023年年报每股收益0.53美元,归母净利润8.54亿美元,同比去年增长-35.3%
|
| 2025-11-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益1.74美元,归母净利润28.24亿美元,同比去年增长143.66%
|
| 2025-08-06 |
详情>>
业绩披露：
2025年中报每股收益0.98美元,归母净利润15.81亿美元,同比去年增长307.47%
|
| 2025-05-07 |
详情>>
业绩披露：
2025年一季报每股收益0.44美元,归母净利润7.09亿美元,同比去年增长476.42%
|
| 2025-03-28 |
股东大会：
将于2025-05-14召开股东大会
会议内容 ▼▲
- 1.Elect the eight director nominees named in this proxy statement;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the current fiscal year;
3.Approve on a non-binding, advisory basis the compensation of our named executive officers (“Say-on-Pay”), as disclosed in this proxy statement pursuant to the compensation disclosure rules of the U.S. Securities and Exchange Commission (the “SEC”);
4.Approve an amendment and restatement of the Company’s Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) to increase the number of authorized shares of common stock from 2.25 billion shares to 4.0 billion shares;
5.Approve an amendment and restatement of the Certificate of Incorporation to limit the liability of certain officers as permitted by Delaware law and to make a non-substantive change;
6.Vote on the stockholder proposal described in this proxy statement, if properly presented at our Annual Meeting;
7.Transact any other business that properly comes before our Annual Meeting or any adjournment or postponement thereof.
|
| 2025-02-05 |
详情>>
业绩披露：
2022年年报每股收益0.85美元,归母净利润13.20亿美元,同比去年增长-58.25%
|
| 2025-02-05 |
详情>>
业绩披露：
2024年年报每股收益1.01美元,归母净利润16.41亿美元,同比去年增长92.15%
|
| 2024-10-30 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.72美元,归母净利润11.59亿美元,同比去年增长519.79%
|
| 2024-07-31 |
详情>>
业绩披露：
2024年中报每股收益0.24美元,归母净利润3.88亿美元,同比去年增长446.43%
|
| 2024-05-01 |
详情>>
业绩披露：
2024年一季报每股收益0.08美元,归母净利润1.23亿美元,同比去年增长188.49%
|
| 2024-03-25 |
股东大会：
将于2024-05-08召开股东大会
会议内容 ▼▲
- 1.Elect the nine director nominees named in this proxy statement;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the current fiscal year;
3.Approve on a non-binding, advisory basis the compensation of our named executive officers (“Say-on-Pay”), as disclosed in this proxy statement pursuant to the compensation disclosure rules of the U.S. Securities and Exchange Commission (the “SEC”);
4.Vote on the stockholder proposal described in this proxy statement, if properly presented at our Annual Meeting;
5.Transact any other business that properly comes before our Annual Meeting or any adjournment or postponement thereof.
|
| 2023-03-31 |
股东大会：
将于2023-05-18召开股东大会
会议内容 ▼▲
- 1.Elect the nine director nominees named in this proxy statement;
2.Approve of the Advanced Micro Devices, Inc. 2023 Equity Incentive Plan;
3.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the current fiscal year;
4.Approve on a non-binding, advisory basis the compensation of our named executive officers (“Say-on-Pay”), as disclosed in this proxy statement pursuant to the compensation disclosure rules of the U.S. Securities and Exchange Commission (the “SEC”);
5.Approve on a non-binding, advisory basis the frequency of future Say-on-Pay votes (“Frequency of Say-on-Pay”);
6.Transact any other business that properly comes before our Annual Meeting or any adjournment or postponement thereof.
|
| 2022-03-31 |
股东大会：
将于2022-05-18召开股东大会
会议内容 ▼▲
- 1.Elect the ten director nominees named in this proxy statement;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the current fiscal year;
3.Approve on a non-binding, advisory basis the compensation of our named executive officers, as disclosed in this proxy statement pursuant to the compensation disclosure rules of the U.S. Securities and Exchange Commission (the “SEC”);
4.Transact any other business that properly comes before our Annual Meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-31 |
股东大会：
将于2021-05-19召开股东大会
会议内容 ▼▲
- 1.Elect the eight director nominees named in this proxy statement;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the current fiscal year;
3.Approve on a non-binding, advisory basis the compensation of our named executive officers, as disclosed in this proxy statement pursuant to the compensation disclosure rules of the U.S. Securities and Exchange Commission (the “SEC”);
4.Transact any other business that properly comes before our Annual Meeting or any adjournment or postponement thereof.
|
| 2021-03-05 |
股东大会：
将于2021-04-07召开股东大会
会议内容 ▼▲
- 1.to approve the issuance of shares of AMD common stock to the stockholders of Xilinx, Inc., which is referred to as “Xilinx,” in connection with the merger contemplated by the Agreement and Plan of Merger, dated October 26, 2020, as it may be amended from time to time, which is referred to as the “merger agreement,” by and among AMD, Thrones Merger Sub, Inc., a wholly owned subsidiary of AMD, and Xilinx, which issuance is referred to as the “share issuance” and which proposal is referred to as the “AMD share issuance proposal”;
2.to approve the adjournment of the AMD special meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the AMD special meeting to approve the AMD share issuance proposal or to ensure that any supplement or amendment to the accompanying joint proxy statement/prospectus is timely provided to AMD stockholders, which proposal is referred to as the “AMD adjournment proposal.”
|
| 2020-03-26 |
股东大会：
将于2020-05-07召开股东大会
会议内容 ▼▲
- 1.Elect the eight director nominees named in this proxy statement;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the current fiscal year;
3.Approve on a non-binding, advisory basis the compensation of our named executive officers, as disclosed in this proxy statement pursuant to the compensation disclosure rules of the U.S. Securities and Exchange Commission (the “SEC”);
4.Transact any other business that properly comes before our Annual Meeting or any adjournment or postponement thereof.
|
| 2019-03-21 |
股东大会：
将于2019-05-15召开股东大会
会议内容 ▼▲
- 1.Elect the seven director nominees named in this proxy statement;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the current fiscal year;
3.Approve the amendment and restatement of the Advanced Micro Devices, Inc. 2004 Equity Incentive Plan (as amended and restated, the “2004 Plan”) to: (i) increase the number of authorized shares that can be awarded to our employees, consultants and directors under the 2004 Plan by 29 million shares and (ii) update the plan for certain tax law changes;
4.Approve on a non-binding, advisory basis the compensation of our named executive officers, as disclosed in this proxy statement pursuant to the compensation disclosure rules of the U.S. Securities and Exchange Commission (the “SEC”);
5.Transact any other business that properly comes before our Annual Meeting or any adjournment or postponement thereof.
|
| 2018-03-19 |
股东大会：
将于2018-05-02召开股东大会
会议内容 ▼▲
- 1.Elect the nine director nominees named in this proxy statement;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the current fiscal year;
3.Approve an amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 1.5 billion shares to 2.25 billion shares;
4.Approve on a non-binding, advisory basis the compensation of our named executive officers, as disclosed in this proxy statement pursuant to the compensation disclosure rules of the U.S. Securities and Exchange Commission (the “SEC”);
5.Transact any other business that properly comes before our Annual Meeting or any adjournment or postponement thereof.
|
| 2017-03-08 |
股东大会：
将于2017-04-26召开股东大会
会议内容 ▼▲
- 1.Elect the eight director nominees named in this proxy statement;
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the current fiscal year;
3.Approve the amendment and restatement of the Advanced Micro Devices, Inc. 2004 Equity Incentive Plan (as amended and restated, the “2004 Plan”) to: (i) increase the number of authorized shares that can be awarded to our employees, consultants and directors under the 2004 Plan by 27 million shares; (ii) to prohibit the payment of dividends on unvested awards; and (iii) re-approve the material terms of the performance goals under the 2004 Plan;
4.Approve the Advanced Micro Devices, Inc. 2017 Employee Stock Purchase Plan;
5.Approve on a non-binding, advisory basis the compensation of our named executive officers (“Say-on-Pay”), as disclosed in this proxy statement pursuant to the compensation disclosure rules of the U.S. Securities and Exchange Commission (the “SEC”);
6.Approve on a non-binding, advisory basis the frequency of future Say-on-Pay votes (“Frequency of Say-on-Pay”);
7.Transact any other business that properly comes before our Annual Meeting or any adjournment or postponement thereof.
|